{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:39:14Z","timestamp":1789231154951,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T00:00:00Z","timestamp":1386028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2013.102","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T09:36:20Z","timestamp":1386063380000},"page":"e330-e330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice"],"prefix":"10.1038","volume":"3","author":[{"given":"A","family":"Trueba-S\u00e1iz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fortea Ormaechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Del Ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Torres-Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,3]]},"reference":[{"key":"BFtp2013102_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm0206-156a","volume":"12","author":"G Sinha","year":"2006","unstructured":"Sinha G . European scientists push spinal taps for Alzheimer diagnosis. Nat Med 2006; 12: 156.","journal-title":"Nat Med"},{"key":"BFtp2013102_CR2","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","volume":"461","author":"RJ Perrin","year":"2009","unstructured":"Perrin RJ, Fagan AM, Holtzman DM . Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 2009; 461: 916\u2013922.","journal-title":"Nature"},{"key":"BFtp2013102_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007; 13: 1359\u20131362.","journal-title":"Nat Med"},{"key":"BFtp2013102_CR4","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1523\/JNEUROSCI.3785-09.2010","volume":"30","author":"AM Fjell","year":"2010","unstructured":"Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D et al. CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J Neurosci 2010; 30: 2088\u20132101.","journal-title":"J Neurosci"},{"key":"BFtp2013102_CR5","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1523\/JNEUROSCI.5180-09.2010","volume":"30","author":"VL Villemagne","year":"2010","unstructured":"Villemagne VL, Perez KA, Pike KE, Kok WM, Rowe CC, White AR et al. Blood-borne amyloid-{beta} dimer correlates with clinical markers of Alzheimer's disease. J Neurosci 2010; 30: 6315\u20136322.","journal-title":"J Neurosci"},{"key":"BFtp2013102_CR6","first-page":"325","volume":"19","author":"R Sperling","year":"2013","unstructured":"Sperling R, Johnson K . Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria. Continuum (Minneap Minn) 2013; 19: 325\u2013338.","journal-title":"Continuum (Minneap Minn)"},{"key":"BFtp2013102_CR7","first-page":"139","volume":"46","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, Frolich L, Hoyer S, Riederer P . Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders? J Neural Transm Suppl 1995; 46: 139\u2013147.","journal-title":"J Neural Transm Suppl"},{"key":"BFtp2013102_CR8","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm1202-793","volume":"8","author":"E Carro","year":"2002","unstructured":"Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I . Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 2002; 8: 1390\u20131397.","journal-title":"Nat Med"},{"key":"BFtp2013102_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2302\/kjm.55.59","volume":"55","author":"E Carro","year":"2006","unstructured":"Carro E, Torres-Aleman I . Serum insulin-like growth factor I in brain function. Keio J Med 2006; 55: 59\u201363.","journal-title":"Keio J Med"},{"key":"BFtp2013102_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ghir.2011.07.006","volume":"21","author":"S Saenger","year":"2011","unstructured":"Saenger S, Goeldner C, Frey JR, Ozmen L, Ostrowitzki S, Spooren W et al. PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders. Growth Hormone & IGF Research 2011; 21: 292\u2013303.","journal-title":"Growth Hormone & IGF Research"},{"key":"BFtp2013102_CR11","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.neurobiolaging.2005.09.039","volume":"27","author":"E Carro","year":"2006","unstructured":"Carro E, Trejo JL, Spuch C, Bohl D, Heard JM, Torres-Aleman I . Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease? Neurobiol Aging 2006; 27: 1618\u20131631.","journal-title":"Neurobiol Aging"},{"key":"BFtp2013102_CR12","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.neuron.2010.08.007","volume":"67","author":"T Nishijima","year":"2010","unstructured":"Nishijima T, Piriz J, Duflot S, Fernandez AM, Gaitan G, Gomez-Pinedo U et al. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 2010; 67: 834\u2013846.","journal-title":"Neuron"},{"key":"BFtp2013102_CR13","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1212\/WNL.0b013e318233b33d","volume":"77","author":"DT Jones","year":"2011","unstructured":"Jones DT, Machulda MM, Vemuri P, McDade EM, Zeng G, Senjem ML et al. Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology 2011; 77: 1524\u20131531.","journal-title":"Neurology"},{"key":"BFtp2013102_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejphar.2004.02.050","volume":"490","author":"E Carro","year":"2004","unstructured":"Carro E, Torres-Aleman I . The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur J Pharmacol 2004; 490: 127\u2013133.","journal-title":"Eur J Pharmacol"},{"key":"BFtp2013102_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012; 122: 1316\u20131338.","journal-title":"J Clin Invest"},{"key":"BFtp2013102_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/jnr.23201","volume":"91","author":"B Zhang","year":"2013","unstructured":"Zhang B, Tang XC, Zhang HY . Alternations of central insulin-like growth factor-1 sensitivity in APP\/PS1 transgenic mice and neuronal models. J Neurosci Res 2013; 91: 717\u2013725.","journal-title":"J Neurosci Res"},{"key":"BFtp2013102_CR17","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.psyneuen.2013.02.006","volume":"38","author":"P Johansson","year":"2013","unstructured":"Johansson P, Aberg D, Johansson JO, Mattsson N, Hansson O, Ahr\u00e9n B et al. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease. Psychoneuroendocrinology 2013; 38: 1729\u20131737.","journal-title":"Psychoneuroendocrinology"},{"key":"BFtp2013102_CR18","doi-asserted-by":"publisher","first-page":"12103","DOI":"10.1073\/pnas.0604404103","volume":"103","author":"O Tschritter","year":"2006","unstructured":"Tschritter O, Preissl H, Hennige AM, Stumvoll M, Porubska K, Frost R et al. The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a\u00a0magnetoencephalographic study. PNAS 2006; 103: 12103\u201312108.","journal-title":"PNAS"},{"key":"BFtp2013102_CR19","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1152\/jn.00089.2003","volume":"89","author":"A Nunez","year":"2003","unstructured":"Nunez A, Carro E, Torres-Aleman I . Insulin-like growth factor I modifies electrophysiological properties of rat brain stem neurons. J Neurophysiol 2003; 89: 3008\u20133017.","journal-title":"J Neurophysiol"},{"key":"BFtp2013102_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1159\/000173710","volume":"26","author":"I Sala","year":"2008","unstructured":"Sala I, Belen Sanchez-Saudinos M, Molina-Porcel L, L\u00e1zaro E, Gich I, Clarim\u00f3n J et al. Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance. Dement Geriatr Cogn Disord 2008; 26: 506\u2013512.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"BFtp2013102_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/mp.2011.128","volume":"17","author":"AM Fernandez","year":"2012","unstructured":"Fernandez AM, Jimenez S, Mecha M, D\u00e1vila D, Guaza C, Vitorica J et al. Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology. Mol Psychiatry 2012; 17: 705\u2013718.","journal-title":"Mol Psychiatry"},{"key":"BFtp2013102_CR22","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/sj.mp.4002076","volume":"12","author":"JL Trejo","year":"2007","unstructured":"Trejo JL, Piriz J, Llorens-Martin MV, Fernandez AM, Bol\u00f3s M, LeRoith D et al. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol Psychiatry 2007; 12: 1118\u20131128.","journal-title":"Mol Psychiatry"},{"key":"BFtp2013102_CR23","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.1073\/pnas.96.13.7324","volume":"96","author":"S Yakar","year":"1999","unstructured":"Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 1999; 96: 7324\u20137329.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2013102_CR24","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1074\/jbc.M101521200","volume":"277","author":"V Aguirre","year":"2002","unstructured":"Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF . Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 2002; 277: 1531\u20131537.","journal-title":"J Biol Chem"},{"key":"BFtp2013102_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0304-3940(97)00304-2","volume":"227","author":"F Wavrant-DeVrieze","year":"1997","unstructured":"Wavrant-DeVrieze F, Perez-tur J, Lambert JC, Frigard B, Pasquier F, Delacourte et al. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett 1997; 227: 68\u201370.","journal-title":"Neurosci Lett"},{"key":"BFtp2013102_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","volume":"88","author":"S Al-Mahdawi","year":"2006","unstructured":"Al-Mahdawi S, Pinto RM, Varshney D, Lawrence L, Lowrie MB, Hughes S et al. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics 2006; 88: 580\u2013590.","journal-title":"Genomics"},{"key":"BFtp2013102_CR27","first-page":"224","volume":"31","author":"AM Moloney","year":"2010","unstructured":"Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C . Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol\u00a0Aging 2010; 31: 224\u2013243.","journal-title":"Neurobiol\u00a0Aging"},{"key":"BFtp2013102_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? J Alzheimers Dis 2005; 7: 63\u201380.","journal-title":"J Alzheimers Dis"},{"key":"BFtp2013102_CR29","doi-asserted-by":"publisher","first-page":"e55531","DOI":"10.1371\/journal.pone.0055531","volume":"8","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Da X, Bhatt P, Wolk DA, Arnold SE, Shaw LM et al. Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI. PLoS ONE 2013; 8: e55531.","journal-title":"PLoS ONE"},{"key":"BFtp2013102_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1096\/fj.06-7703com","volume":"22","author":"WQ Zhao","year":"2007","unstructured":"Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ et al. Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 2007; 22: 246\u2013260.","journal-title":"FASEB J"},{"key":"BFtp2013102_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","volume":"12","author":"T Kondo","year":"2013","unstructured":"Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y et al. Modeling Alzheimers disease with iPSCs reveals stress phenotypes associated with intracellular a\u00a6 and differential drug responsiveness. Cell Stem Cell 2013; 12: 487\u2013496, Ref Type: Abstract.","journal-title":"Cell Stem Cell"},{"key":"BFtp2013102_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1126\/science.1103160","volume":"306","author":"U Ozcan","year":"2004","unstructured":"Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306: 457\u2013461.","journal-title":"Science"},{"key":"BFtp2013102_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrn3209","volume":"13","author":"AM Fernandez","year":"2012","unstructured":"Fernandez AM, Torres-Aleman I . The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci 2012; 13: 225\u2013239.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp2013102_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12017-007-8011-0","volume":"9","author":"MO Dietrich","year":"2007","unstructured":"Dietrich MO, Muller A, Bolos M, Carro E, Perry ML, Portela LV et al. Western style diet impairs entrance of blood-borne insulin-like growth factor-1 into the brain. Neuromolecular Med 2007; 9: 324\u2013330.","journal-title":"Neuromolecular Med"},{"key":"BFtp2013102_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(99)00847-2","volume":"277","author":"JC Dodart","year":"1999","unstructured":"Dodart JC, Mathis C, Bales KR, Paul SM, Ungerer A . Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Neurosci Lett 1999; 277: 49\u201352.","journal-title":"Neurosci Lett"},{"key":"BFtp2013102_CR36","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.neurobiolaging.2005.06.015","volume":"27","author":"E Carro","year":"2006","unstructured":"Carro E, Trejo JL, Gerber A, Loetscher H, Torrado J, Metzger F et al. Therapeutic actions of insulin-like growth factor I on APP\/PS2 mice with severe brain amyloidosis. Neurobiol Aging 2006; 27: 1250\u20131257.","journal-title":"Neurobiol Aging"},{"key":"BFtp2013102_CR37","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/archneurol.2012.1970","volume":"69","author":"LD Baker","year":"2012","unstructured":"Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial\u00a0. Arch Neurol 2012; 69: 1420\u20131429.","journal-title":"Arch Neurol"},{"key":"BFtp2013102_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JAD-2011-111076","volume":"28","author":"LD Baker","year":"2012","unstructured":"Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA, Callaghan M et al. High-intensity physical activity modulates diet effects on cerebrospinal amyloid-beta levels in normal aging and mild cognitive impairment. J Alzheimers Dis 2012; 28: 137\u2013146.","journal-title":"J Alzheimers Dis"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tp2013102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tp2013102","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2013102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T16:56:29Z","timestamp":1672937789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2013102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,3]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12]]}},"alternative-id":["BFtp2013102"],"URL":"https:\/\/doi.org\/10.1038\/tp.2013.102","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,3]]},"assertion":[{"value":"22 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AT-S, CC, AN and IT-A\u00a0have filled a patent application describing this method as a diagnostic tool for AD. The remaining authors declare\u00a0no conflict of interest.\u00a0","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}